Valganciclovir Hydrochloride Powder, For Solution
Product Images NDC 27241-159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 27241-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

→ Structure (valgacyclovir Structure)

→ Valganciclovir 50mg

→ Valganciclovir Carton

→ Valganciclovir Fig1

→ Formula2 (valganciclovir Image2)

→ Valganciclovir Step1

→ Valganciclovir Step10

→ Valganciclovir Step11

→ Valganciclovir Step2

→ Valganciclovir Step3

→ Valganciclovir Step4

→ Valganciclovir Step5

→ Valganciclovir Step6

→ Valganciclovir Step7

→ Valganciclovir Step8

→ Valganciclovir Step9

→ Formula- (valgavcyclovir Formula 1)

FDA Label Image

Structure (Valgacyclovir Structure)

FDA Label Image

Valganciclovir 50mg

Valganciclovir for oral solution is a prescription medication that comes in an original bottle that is child-proof. The dry powder can be stored at room temperature, while the solution should be kept refrigerated. Once the solution is constituted, it should be used within 49 days of preparation. The constituted oral solution should be handled with care and the original bottle should be tightly closed. The solution has a Net contents of 100 mL, containing 5 grams of Valganciclovir free base. To dispense, prepare the solution at the time of dispensing by measuring 91 mL of purified water.*

FDA Label Image

Valganciclovir Carton

The text provides instructions for preparing and using Valganciclovir for oral solution to treat cytomegalovirus. It includes information about measuring the powder, adding water, shaking, and the proper storage and use of the solution after mixing. The solution contains 50mg of Valganciclovir per mL and should be used within 49 days after preparation. The product is made by Ajanta Pharma USA Inc. and includes dry powder, a bottle adapter, and two oral dispensers. The text also provides dosage information and warnings about proper storage, and suggests referring to enclosed patient instructions for use.*

FDA Label Image

Valganciclovir Fig1

FDA Label Image

Formula2 (Valganciclovir Image2)

This text describes a formula to calculate creatinine clearance based on the patient's height and serum creatinine levels. However, the value of "k" is not provided in the text.*

FDA Label Image